New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
November 24, 2023 08:55 ET | SciSparc Ltd
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Lindsey Sneed
Study: Autistic Children May Need Fewer Hours of Treatment Than Previously Thought
November 21, 2023 13:41 ET | Catalight
Walnut Creek, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Each year, tens of thousands of parents and caregivers of children with autism spectrum disorder (ASD) face vital decisions: What kind of...
YAMO LOGO-hi rez.png
Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder
November 20, 2023 08:05 ET | Yamo Pharmaceuticals
Yamo Pharmaceuticals LLC has completed enrollment in its Phase 2 study evaluating L1-79 in adolescents with autism spectrum disorder (ASD).
Healthy People 2030
Catalight Honored as a Healthy People 2030 Champion from Department of Health and Human Services
November 15, 2023 13:40 ET | Catalight
Walnut Creek, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Citing the company’s bold vision for the future, Catalight was recently named a Healthy People 2030 Champion by the Office of Disease...
Global Neurological Biomarkers Market
Neurological Biomarkers Research Report 2023: A Global $18.75 Billion Market by 2030 with Pipeline Analysis of Alzheimer's, Parkinson's, Multiple Sclerosis, & Autism Spectrum Disorder
November 14, 2023 05:28 ET | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), By Type,...
NeuroQure Logo.png
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
November 06, 2023 12:00 ET | NeuroQure
IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the treatment landscape for Fragile X Syndrome and Autism Spectrum...
Hopebridge Standardizes Circle Time Curriculum
Hopebridge Launches Standardized Circle Time Curriculum in Autism Therapy Centers Across the Country
October 30, 2023 08:00 ET | Hopebridge
Indianapolis, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Children with autism spectrum disorder (ASD) will now have even more support in their transition to school due to an innovative Circle Time Curriculum...
AXIAL Logo 2021MAR05.png
Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
September 26, 2023 08:00 ET | Axial Therapeutics
– Topline clinical data anticipated in 1Q 2024 – – First-in-class small molecule therapeutic targets the microbiome gut-brain axis and its role in autism, offering a potential alternative to...
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
September 12, 2023 08:00 ET | Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
My Friend Julia: A Sesame Street Book about Autism
Celebrate a New Sesame Street Friend with My Friend Julia: A Sesame Street® Book about Autism by Jennifer Cook
September 07, 2023 12:08 ET | Lerner Publishing Group
Minneapolis, Minnesota, Sept. 07, 2023 (GLOBE NEWSWIRE) -- This September, Lerner Publications™, an imprint of Lerner Publishing Group™, presents My Friend Julia: A Sesame Street® Book about Autism...